|
業務類別
|
Biotechnology |
|
業務概覽
|
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approvedfor wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia). |
| 公司地址
| 777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707 |
| 電話號碼
| +1 914 847-7000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.regeneron.com |
| 員工數量
| 15410 |
| Mr. Andrew J Murphy |
Executive Vice President and Co-Chief Scientific Officer |
美元 819.67K |
24/04/2026 |
| Mr. Jason Pitofsky |
Senior Vice President and Controller |
-- |
24/04/2026 |
| Mr. Christopher R. Fenimore |
Executive Vice President, Finance and Chief Financial Officer |
美元 725.00K |
24/04/2026 |
| Ms. Marion McCourt |
Executive Vice President, Commercial |
-- |
24/04/2026 |
| Mr. Daniel P. Van Plew |
Executive Vice President and General Manager, Industrial Operations and Product Supply |
美元 983.38K |
24/04/2026 |
| Mr. Joseph J. Larosa |
Executive Vice President, General Counsel and Secretary |
美元 916.06K |
24/04/2026 |
| Dr. George D. Yancopoulos,M.D.,PhD |
Co-Chairman of the Board, Co-President and Chief Scientific Officer |
美元 1.98M |
24/04/2026 |
| Dr. Leonard S. Schleifer,M.D.,PhD |
Co-Chairman of the Board, Co-President and Chief Executive Officer |
美元 1.98M |
24/04/2026 |
|
|
| Dr. Huda Y. Zoghbi, M.D. |
Independent Director |
24/04/2026 |
| Ms. Kathryn Guarini, PhD |
Independent Director |
24/04/2026 |
| Dr. David P. Schenkein, M.D. |
Independent Director |
24/04/2026 |
| Dr. Bonnie L. Bassler, PhD |
Independent Director |
24/04/2026 |
| Mr. George L. Sing |
Independent Director |
24/04/2026 |
| Dr. George D. Yancopoulos,M.D.,PhD |
Co-Chairman of the Board, Co-President and Chief Scientific Officer |
24/04/2026 |
| Ms. Christine A. Poon |
Lead Independent Director |
24/04/2026 |
| Dr. Craig B. Thompson,M.D. |
Independent Director |
24/04/2026 |
| Dr. Michael S. Brown, M.D. |
Independent Director |
24/04/2026 |
| Dr. N. Anthony Coles, M.D. |
Independent Director |
24/04/2026 |
| Dr. Joseph L. Goldstein,M.D. |
Independent Director |
24/04/2026 |
| Dr. Leonard S. Schleifer,M.D.,PhD |
Co-Chairman of the Board, Co-President and Chief Executive Officer |
24/04/2026 |
| Mr. Arthur Frederick Ryan |
Independent Director |
24/04/2026 |
|
|
|
|
